Who are the peers of the Glenmark Pharma?

Peers: Glenmark Pharma's peers are Dr Reddy's Labs, Zydus Lifesci., Lupin, Abbott India, Aurobindo Pharma, Alkem Lab, Glaxosmi. Pharma, Biocon, Laurus Labs.
Quality Snapshot: Excellent management risk is observed at Dr Reddy's Labs, Abbott India, and Glaxosmi. Pharma, while Good management risk is found at Zydus Lifesci., Aurobindo Pharma, Alkem Lab, and Laurus Labs. Average management risk is present at Lupin, Glenmark Pharma, and Biocon. In terms of Growth, Excellent growth is seen at Dr Reddy's Labs and Zydus Lifesci., while Average growth is noted at Abbott India and Laurus Labs, and Below Average growth is found at Aurobindo Pharma, Glenmark Pharma, Alkem Lab, Glaxosmi. Pharma, and Biocon. For Capital Structure, Excellent capital structure is observed at Dr Reddy's Labs, Zydus Lifesci., Abbott India, Aurobindo Pharma, and Glaxosmi. Pharma, while Good capital structure is present at Glenmark Pharma, and Average capital structure is seen at Laurus Labs and Biocon.

Return Snapshot: Glenmark Pharma has a 1-year return of 56.34%, while the highest return is from Laurus Labs at 76.44% and the lowest is from Zydus Lifesci. at -18.37%. Glenmark Pharma's return is significantly higher than Zydus Lifesci.'s. Additionally, Aurobindo Pharma and Alkem Lab have negative six-month returns.